Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract Source

Journal article

Open access

Peer reviewed

Truc T Tran, Hannah R Palmer, Marion R Weimar, Cesar A Arias, Gregory M Cook and Barbara E Murray

Clinical infectious diseases, Vol.60(11), pp.1726-1728

01/06/2015

Handle:

https://hdl.handle.net/10523/37057

Abstract

Adult

Anti-Bacterial Agents - administration & dosage

Bacitracin - administration & dosage

Bacitracin - pharmacology

Bacteremia - drug therapy

Daptomycin - pharmacology

Doxycycline - administration & dosage

Gastrointestinal Tract - microbiology

Humans

Microbial Sensitivity Tests

Vancomycin-Resistant Enterococci - drug effects

url

https://doi.org/10.1093/cid/civ130View

Published (Version of record) Open

4 Record Views

Record Identifier: 9926529224101891
Title: Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract Source
Creators: Truc T Tran
Hannah R Palmer
Marion R Weimar
Cesar A Arias
Gregory M Cook
Barbara E Murray
Publication Details: Clinical infectious diseases, Vol.60(11), pp.1726-1728
Academic Unit: Microbiology and Immunology
Grant note: R21 AI103260 / NIAID NIH HHS K08 AI113317 / NIAID NIH HHS R01 AI 093749 / NIAID NIH HHS R01AI047923-14 / NIAID NIH HHS R21 AI103260-01 / NIAID NIH HHS R01 AI047923 / NIAID NIH HHS R01 AI093749 / NIAID NIH HHS K08 AI 113317 / NIAID NIH HHS
Date published ; e-published: 01/06/2015
Language: English
Resource Type ; Subtype: Journal article